- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
In the early stages of treatment, some users of digotinib ointment may experience localized burning sensation, dry skin, or worsening erythema....
Delgocitinib ointment is used for local treatment of atopic dermatitis. The correct application sequence, frequency, and discontinuation method...
Although terbotinib is a targeted drug, it is still necessary to be vigilant about the specific toxic reactions of the four major organ systems...
Not all patients are suitable for using tepotinib. The following three groups of people are clearly classified as contraindicated or require ex...
Adverse reactions during treatment are common, and active management can significantly improve quality of life. The following are home treatmen...
To ensure efficacy and safety, please strictly follow the following core operating procedures. All adjustments must be confirmed in writing by ...
During the treatment of diseases such as bone marrow fibrosis, several important safety risks need to be closely monitored. Understanding these...
Ruxolitinib, as a JAK inhibitor, can regulate immune response but may also increase the risk of infection. The following groups of people need ...
Lucretinib may cause side effects such as dizziness, bruising, and weight gain during the treatment process. Mastering scientific coping method...
The standardized use of Ruxolitinib directly affects the efficacy and safety. Mastering the correct way of taking medication, principles of dos...
